Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Total Liabilities: 2009-2025

Historic Total Liabilities for BIO-TECHNE (TECH) over the last 17 years, with Jun 2025 value amounting to $639.1 million.

  • BIO-TECHNE's Total Liabilities fell 6.20% to $560.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $560.3 million, marking a year-over-year decrease of 6.20%. This contributed to the annual value of $639.1 million for FY2025, which is 0.64% up from last year.
  • Per BIO-TECHNE's latest filing, its Total Liabilities stood at $639.1 million for FY2025, which was up 0.64% from $635.0 million recorded in FY2024.
  • In the past 5 years, BIO-TECHNE's Total Liabilities ranged from a high of $691.7 million in FY2021 and a low of $593.8 million during FY2022.
  • Its 3-year average for Total Liabilities is $648.8 million, with a median of $639.1 million in 2025.
  • In the last 5 years, BIO-TECHNE's Total Liabilities fell by 14.16% in 2022 and then rose by 13.20% in 2023.
  • Yearly analysis of 5 years shows BIO-TECHNE's Total Liabilities stood at $691.7 million in 2021, then fell by 14.16% to $593.8 million in 2022, then increased by 13.20% to $672.2 million in 2023, then dropped by 5.53% to $635.0 million in 2024, then grew by 0.64% to $639.1 million in 2025.